Topiramate Capsule, Extended Release
Product Images NDC 70710-1039

This appears to be a table showing the proportion of patients experiencing different degrees of reduction in seizure frequency from baseline while taking either a placebo or a 200 mg/day extended-release dose of topiramate capsules. There is no clear heading, but the values in the table range from 0-100 and are organized into columns by treatment group, with a row indicating the degree of seizure reduction.*

This appears to be a table of results obtained from a study evaluating the effectiveness of Topiramate in treating migraine headaches, compared to a placebo. The table shows the change in average monthly migraine period rate for different dosages of Topiramate and the placebo, with corresponding sample sizes for each group. The results are presented as +SE (standard error). The significance of the results is also noted at the bottom of the table, with the level of statistical significance being denoted by asterisks.*

The text is a label for a medication package of Topiramate Toprate USPr— 25 mg in extended-release capsules. The package is child-resistant and the medication should be kept out of reach of children. The package includes dosing instructions and a medication guide URL for patients. The label also includes information about storage temperature and a phone number to call for assistance. The product is manufactured by Zydus Lifesciences Ltd.*

Not available. The text contains only a few product details and a lot of gibberish/irrelevant characters.*

This is the description of a Topiramate Extended-Release Capsule medication that comes in a 30-capsules package. Each capsule contains 100 mg of Topiramate, USP, with a recommended dosage of once daily. The package is child-resistant, and it should be stored in a tightly closed container at the temperature range of 20°C to 35°C. A medication guide is available at wrn 2ydusuca comimedguides or, for inquiries, customers may call 14179838173. The medication is distributed by Zydus Pharmaceuticals (USA)Inc., from the location in Pemningion, NJ 06534. The rest of the text appears to be information related to the coding and labeling of the medication, and it is not relevant to the description.*

This is a description of a medication in capsule form. The medication is Topiramate extended-release capsules which are to be taken once daily with a recommended dosage of 150mg. The pills come in a package of 30 capsules and are prescribed by a pharmacist. The pills should be kept in a tightly sealed container at a temperature between 2°C to 25°C (68°F to 77°F) and should be protected from moisture. The medication guide is available at 2ydususa.com or by calling 1-977-983-8179. The manufacturer is Zydus Lifesciences Ltd, based in India, and distributed by Zydus Pharmaceuticals (USA) Inc.*

Description: Topiramate is an extended-release capsule used for once-daily dosing. Each capsule contains 200mg of Topramate, USP. The recommended dosage is to administer once daily by following the prescribing information. The package is child-resistant, and the medication should be stored in a tightly closed container at 20 to 25°C or 66°F to 77°F with excursions between 15°C to 30°C or 59°F to 86°F. The medication guide is available at www.zydususa.com/medguides or contact 1-877-993-8779. This medication is made by Zydus Lifesciences Ltd in Ahmedabad, India, and distributed by Zydus Pharmaceuticals (USA) Inc.*